GE Vernova Inc. (BIT:1GEV)
534.00
-28.00 (-4.98%)
At close: Aug 13, 2025, 5:30 PM CET
Aerovate Therapeutics Revenue
GE Vernova had revenue of $9.11B USD in the quarter ending June 30, 2025, with 11.06% growth. This brings the company's revenue in the last twelve months to $36.62B, up 8.45% year-over-year. In the year 2024, GE Vernova had annual revenue of $34.94B with 5.10% growth.
Revenue (ttm)
$36.62B
Revenue Growth
+8.45%
P/S Ratio
4.92
Revenue / Employee
$476.76K
Employees
76,800
Market Cap
153.31B
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 34.94B | 1.70B | 5.10% |
Dec 31, 2023 | 33.24B | 3.59B | 12.09% |
Dec 31, 2022 | 29.65B | -3.35B | -10.16% |
Dec 31, 2021 | 33.01B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition